Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
!!Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Should hemoglobin be normalized in uremic patients?
R. N. Foley
Medicine - Renal and Hypertension Division
Research output
:
Contribution to journal
›
Review article
›
peer-review
3
!!Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Should hemoglobin be normalized in uremic patients?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Chronic Kidney Disease
100%
Quality of Life
100%
Anemia
100%
Hemoglobin
100%
Cardiac Failure
100%
Uremic Patients
100%
Cardiovascular Mortality
50%
Cardiomyopathy
50%
Major Adverse Cardiovascular Events
50%
Prospective Observational Study
50%
Hypertension
50%
Intervention Studies
50%
Cardiovascular Disease
50%
Renal Function
50%
End-stage Renal Disease
50%
Mortality Rate
50%
Hospitalization
50%
Left Ventricular Dysfunction
50%
Cardiovascular System
50%
Dialysis Patients
50%
Hemodynamic Load
50%
Premature Senescence
50%
Left Ventricular Function
50%
Functional Status
50%
Uremia
50%
Left Ventricular Size
50%
Cardiac Death
50%
Cardiac Decompensation
50%
Functional Survival
50%
Left Ventricular Enlargement
50%
Physiological Approach
50%
Supraphysiological
50%
Anemia Management
50%
Stress Minimization
50%
Dialysis Treatment
50%
Unanswerable Questions
50%
Independent Risk Factors
50%
Poor Quality of Life
50%
Sine qua Non
50%
Medicine and Dentistry
Quality of Life
100%
Anemia
100%
Congestive Heart Failure
100%
Hemoglobins
100%
Cardiovascular System
100%
Chronic Kidney Disease
66%
Observational Study
66%
Hemodynamic
66%
Clinical Study
33%
Heart Left Ventricle Failure
33%
Myocardial Disease
33%
Prematurity
33%
Cardiovascular Disease
33%
Kidney Function
33%
Left Ventricular Hypertrophy
33%
Mortality Rate
33%
End Stage Renal Disease
33%
Renal Replacement Therapy
33%
Heart Death
33%
Intervention Trial
33%
Functional Status
33%
Uremia
33%
Hypertension
33%
Nursing and Health Professions
Congestive Heart Failure
100%
Anemia
100%
Hemoglobins
100%
Cardiovascular System
100%
Quality of Life
100%
Chronic Kidney Failure
66%
Hemodynamic
66%
Heart Left Ventricle Hypertrophy
33%
Functional Status
33%
Mortality Rate
33%
Prematurity
33%
Heart Left Ventricle Failure
33%
End Stage Renal Disease
33%
Heart Death
33%
Myocardial Disease
33%
Cardiovascular Disease
33%
Renal Replacement Therapy
33%
Uremia
33%
Hypertension
33%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Anemia
100%
Hemoglobins
100%
Observational Study
66%
Chronic Kidney Failure
66%
Clinical Study
33%
Intervention Trial
33%
End Stage Renal Disease
33%
Prematurity
33%
Mortality Rate
33%
Heart Left Ventricle Hypertrophy
33%
Functional Status
33%
Heart Left Ventricle Failure
33%
Heart Death
33%
Myocardial Disease
33%
Uremia
33%
Cardiovascular Disease
33%
Hypertension
33%